Chemical and Pharmaceutical Bulletin p. 28 - 36 (1999)
Update date:2022-08-04
Topics:
Suzuki, Tomoo
Oka, Mitsuru
Maeda, Kouji
Furusawa, Kenichi
Uesaka, Hiroshi
Kataoka, Tadashi
In order to develop drugs effective against Alzheimer's disease, we synthesized a series of aniline derivatives having a characteristic cyclic amine, 1-azabicyclo[3.3.0]octane ring, and evaluated their binding affinity for the central muscarinic cholinergic receptor. Among these compounds which showed high affinity to the M1 receptor, N-[2-(1-Azabicyclo[3.3.0]octan-5- yl)ethyl]-2-nitroaniline (9f fumarate, SK-946) showed the highest affinity. The ability of this compound to improve cognitive function was assessed using the passive avoidance test in scopolamine-induced dementia mice. Some anilines with a 1-azabicyclo[3.3.1]nonane ring were also synthesized by the ring expansion of the 1-azabicyclo[3.3.0]octane ring, and showed a high affinity for the central muscarinic cholinergic receptor.
View MoreHunan Shineway Enterprise Co., Ltd.
Contact:+86-731-86303875
Address:118, Huanghua International Airport Road, Huanghua Town, Changsha, Hunan 410137, China
Hangzhou Yanshan Chemical Co.,Ltd.
Contact:86-571- 87698076
Address:Room 1001, #1 Building, Zhongtian MCC, No.2 Youzhinong, Wenyi West Road, Xihu District, Hangzhou, China
Hefei Highzone Fine Chemical S&T CO.,LTD
Contact:86-0551-63663560
Address:room 1801 NO. 24 Shuguang RD.
Contact:0086-27-83607103/83642615
Address:No.498, Jianshe Ave, Wuhan, China
Chongqing Shuangfeng Chemical Co.,Ltd
Contact:+86-23-49850156
Address:No.663,xuanhua Rd,yongchuan,chongqing,China
Doi:10.1016/0957-4166(95)00162-I
(1995)Doi:10.1021/ja00118a026
(1995)Doi:10.1016/0040-4039(95)00744-W
(1995)Doi:10.1021/acs.joc.0c01514
(2020)Doi:10.3762/bjoc.13.69
(2017)Doi:10.1021/ja00271a074
(1986)
